TY - JOUR
T1 - Prevention of overt hypoglycemia during exercise
T2 - Stimulation of endogenous glucose production independent of hepatic catecholamine action and changes in pancreatic hormone concentration
AU - Coker, Robert H.
AU - Koyama, Yoshiharu
AU - Denny, Joshua C.
AU - Camacho, Raul C.
AU - Brooks Lacy, D.
AU - Wasserman, David H.
PY - 2002
Y1 - 2002
N2 - These studies were conducted to determine the magnitude and mechanism of compensation for impaired glucagon and insulin responses to exercise. For this purpose, dogs underwent surgery >16 days before experiments, at which time flow probes were implanted and silastic catheters were inserted. During experiments, glucagon and insulin were fixed at basal levels during rest and exercise using a pancreatic clamp with glucose clamped (PC/GC; n = 5), a pancreatic clamp with glucose unclamped (PC; n = 7), or a pancreatic clamp with glucose unclamped + intraportal propranolol and phentolamine hepatic α-and β-adrenergic receptor blockade (PC/HAB; n = 6). Glucose production (Ra) was measured isotopically. Plasma glucose was constant in PC/GC, but fell from basal to exercise in PC and PC/HAB. Ra was unchanged with exercise in PC/GC, but was slightly increased during exercise in PC and PC/HAB. Despite minimal increases in epinephrine in PC/GC, epinephrine increased approximately sixfold in PC and PC/HAB during exercise. In summary, during moderate exercise, 1) the increase in Ra is absent in PC/GC; 2) only a moderate fall in arterial glucose occurs in PC, due to a compensatory increase in Ra; and 3) the increase in Ra is preserved in PC/HAB. In conclusion, stimulation of Ra by a mechanism independent of pancreatic hormones and hepatic adrenergic stimulation is a primary defense against overt hypoglycemia.
AB - These studies were conducted to determine the magnitude and mechanism of compensation for impaired glucagon and insulin responses to exercise. For this purpose, dogs underwent surgery >16 days before experiments, at which time flow probes were implanted and silastic catheters were inserted. During experiments, glucagon and insulin were fixed at basal levels during rest and exercise using a pancreatic clamp with glucose clamped (PC/GC; n = 5), a pancreatic clamp with glucose unclamped (PC; n = 7), or a pancreatic clamp with glucose unclamped + intraportal propranolol and phentolamine hepatic α-and β-adrenergic receptor blockade (PC/HAB; n = 6). Glucose production (Ra) was measured isotopically. Plasma glucose was constant in PC/GC, but fell from basal to exercise in PC and PC/HAB. Ra was unchanged with exercise in PC/GC, but was slightly increased during exercise in PC and PC/HAB. Despite minimal increases in epinephrine in PC/GC, epinephrine increased approximately sixfold in PC and PC/HAB during exercise. In summary, during moderate exercise, 1) the increase in Ra is absent in PC/GC; 2) only a moderate fall in arterial glucose occurs in PC, due to a compensatory increase in Ra; and 3) the increase in Ra is preserved in PC/HAB. In conclusion, stimulation of Ra by a mechanism independent of pancreatic hormones and hepatic adrenergic stimulation is a primary defense against overt hypoglycemia.
UR - https://www.scopus.com/pages/publications/0036312721
U2 - 10.2337/diabetes.51.5.1310
DO - 10.2337/diabetes.51.5.1310
M3 - Article
C2 - 11978626
AN - SCOPUS:0036312721
SN - 0012-1797
VL - 51
SP - 1310
EP - 1318
JO - Diabetes
JF - Diabetes
IS - 5
ER -